Overproduction and unrestrained activity of MMP2 has been linked to malignancy in a variety of tumors, including brain, prostate, colorectal, pancreatic, breast, and ovarian tumors, and has been associated with shorter disease-free survival [29–33]. This evidence concerns the gene MMP2 and ovarian neoplasm.